The FDA approved a once-monthly autoinjector for Lerochol (lerodalcibep-liga) and added language to the prescribing information noting that cardiovascular outcomes trials with statins and monoclonal...
New guideline recommendations from the ACC/AHA and 9 partner organizations prioritize earlier treatment, refined atherosclerotic cardiovascular disease risk prediction, and broader use of lipid biomarkers...
Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.
The GOULD study is a multicenter, observational registry of patients with atherosclerotic cardiovascular disease in which the primary endpoint was to describe LDL-C treatment patterns over time in patients...
Low levels of LDL cholesterol reduce the risk of cardiovascular disease and events. However, is it safe to reduce LDL cholesterol levels that are already low? A new study investigates.